Danimer Scientific, Inc.: Nasdaq/NYSE listing notice — Danimer Scientific gets NYSE delisting notice; common stock to trade on OTCQX

Danimer Scientific, Inc.

NYSE notified Danimer on Dec 30 of delisting for failing to maintain avg global market cap ≥ $15M over 30 days.
Trading on NYSE suspended after Dec 30 close; common stock expected to trade on OTCQX under DNMR from Dec 31.
Company assessing appeal; if no appeal, delisting effective 10 days after NYSE files Form 25 with SEC.
Delisting does not affect business operations or SEC reporting obligations.
Warrants (DNMRW) continue trading on OTCQX.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Danimer Scientific, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

Exchange: nyse
Notice: delisting notice
Deficiency: market value
Rules: 802.01B

Exact text from the filing

December 30, 2024, the New York Stock Exchange (“NYSE”) notified Danimer Scientific Inc. (“Danimer” or the “Company”) that it has determined to commence proceedings to delist the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), as a result of the Company’s non-compliance with Rule 802.01B of the NYSE Listed Company Manual that requires listing companies to maintain an average global market capitalization of at least $15 million over a period of 30 consecutive trading days. Trading in the Common Stock on the NYSE was suspended after market close on December 30

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-24-141335

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.